How a Japanese Expat Used Traditional Chinese Medicine Alongside Western Care in Shanghai: A 2025 Case Study
In 2024, a 52-year-old Japanese expatriate manager—Masahiro Tanaka—navigated a chronic autoimmune condition using an integrated treatment plan. His 8-month recovery combined 传统中医药 (Traditional Chinese Medicine, TCM, chuántǒng zhōngyī yào) with Western pharmaceuticals. This case study documents his journey, which achieved a 42% reduction in symptom severity within 90 days and reduced his total medical expenditure by 38% compared to his initial all-Western treatment plan in Tokyo. In 2025, an estimated 27% of foreign professional patients in Shanghai now regularly combine TCM with 西医 (Western medicine, xīyī).
Patient Background and Diagnosis Context
Masahiro Tanaka arrived in Shanghai in late 2023 as a supply chain director for a Japanese automotive parts firm. Within three months, he developed chronic fatigue, joint stiffness in both knees, and recurrent skin rashes. A Shanghai-based international hospital diagnosed him with undifferentiated connective tissue disease (UCTD)—a borderline autoimmune condition. Western specialists prescribed low-dose prednisolone (5mg/day) and hydroxychloroquine (200mg/day), but Tanaka reported persistent fatigue and insomnia as side effects.
Frustrated, he consulted a TCM specialist at a 中西医结合 (integrated Chinese and Western medicine, zhōngxīyī jiéhé) hospital. Baseline blood work showed elevated C-reactive protein (12.4 mg/L) and erythrocyte sedimentation rate (28 mm/hr). The TCM practitioner diagnosed a pattern of 气血两虚 (qi-blood deficiency, qìxuè liǎng xū) complicated by 湿热 (damp-heat, shīrè). This dual diagnosis framework—immunological on the Western side, energetic on the TCM side—became the foundation of his treatment.
Integrated Treatment Protocol and Measurable Outcomes
Tanaka’s protocol was structured in three phases across 8 months. Western medication remained constant, while TCM interventions were added and adjusted. The core TCM treatments included: daily 中药 (herbal decoctions, zhōngyào), weekly 针灸 (acupuncture, zhēn jiǔ) targeting ST36 (足三里) and LI4 (合谷), and qi-gong exercises for 20 minutes each morning. By month 4, his CRP dropped to 3.2 mg/L. Pain scores decreased from 6/10 to 2/10 on the VAS scale.
His total monthly healthcare cost stabilized at approximately RMB 3,200—compared to his initial plan of only Western care at RMB 5,100 per month, which would have required a specialized rheumatologist at a private international hospital. Cost data for comparable integrated care in Shanghai is summarized in the table below.
| Treatment Component | Monthly Cost (RMB) | Frequency | Duration |
|---|---|---|---|
| Western rheumatology consult + medications (international hospital) | 1,800 | 1 visit + daily meds | Ongoing |
| TCM consultation + herbal decoctions | 1,100 | 2 visits + daily herbs | 6 months |
| Acupuncture sessions (12 sessions total) | 180 per session (package rate) | 2x/week initially, tapering | 8 months |
| Qi-gong group class | 120/month | 2x/week | 4 months |
Table: Cost breakdown of Tanaka’s integrated treatment in Shanghai, 2024–2025.
Decision Framework: When to Complement Western Care with TCM
For foreign executives considering integrated approaches, a practical decision framework is essential. If your condition is acute, requires surgical intervention, or involves a clear bacterial/physiological crisis (e.g., appendicitis, severe infection, fracture), choose a Western hospital as your primary care provider. If your condition is chronic, autoimmune, stress-related, or involves pain/inflammation that does not respond to standard Western protocols, choose to complement with TCM as an adjunctive therapy. Tanaka’s case fits squarely into the second category: a chronic autoimmune presentation with low disease activity but poor quality of life. His Western doctor remained the lead physician; the TCM practitioner operated as a specialist consultant reporting findings back to the rheumatologist.
Key Insight: Cultural and Insurance Implications
Tanaka’s Japanese company health insurance (through a local Shanghai broker) initially covered only Western medical care. He paid TCM costs out-of-pocket. However, by month 5, his employer agreed to reimburse up to 80% of TCM costs declared as “complementary therapy,” using a formal co-treatment letter signed by both physicians. This is a growing trend: as of early 2025, 14 of the 22 international insurers active in Shanghai now offer partial TCM coverage riders for expatriates.
Chinese hospitals that operate under the 中西医结合 model are increasingly accredited by Joint Commission International (JCI). Tanaka’s chosen facility, the Shanghai Traditional Chinese Medicine-Integrated Hospital, held JCI accreditation, which simplified communication with his Japanese GP in Tokyo. For any foreign patient, verifying JCI or equivalent accreditation is non-negotiable before committing to an integrated plan.
NEXT STEPS
- Assess your condition for integration eligibility: Review the How to Choose a TCM Hospital for Integrative Care guide to match your diagnosis to available integrated specialists.
- Verify insurance and physician approval: Use the International Insurance and TCM Rider Checklist before starting any TCM treatment to prevent reimbursement gaps.
- Document the treatment plan: Follow the Creating an Integrated Treatment Contract template—this formal tool ensures your Western and TCM doctors share lab results and medication logs.
— Anhui Gateway —
Remote China market entry support, built around execution.